$AMLX
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Joshua Cohen
CEO
123
Employees
$33.64
Current Price
$1.17B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 10 | $2,944,962.28 | 91,302 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 10 | $2,944,962.28 | 91,302 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 10 | $2,944,962.28 | 91,302 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 12 | $3,483,829.78 | 121,302 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Bedrosian Camille L Chief Medical Officer | Sale | 7,947 | $32.21 | $256,003.86 | View Details |
| Sep 10, 2026 | Bedrosian Camille L Chief Medical Officer | Sale | 2,081 | $33.09 | $68,864.24 | View Details |
| Sep 10, 2026 | FRATES JAMES M Chief Financial Officer | Sale | 9,768 | $32.27 | $315,194.80 | View Details |
| Sep 10, 2026 | FRATES JAMES M Chief Financial Officer | Sale | 1,042 | $33.23 | $34,625.87 | View Details |
| Sep 10, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 11 | $33.34 | $366.74 | View Details |
| Sep 10, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 9,525 | $32.46 | $309,139.59 | View Details |
| Sep 10, 2026 | Klee Justin B. Director | Sale | 29,025 | $32.13 | $932,552.93 | View Details |
| Sep 10, 2026 | Klee Justin B. Director | Sale | 1,439 | $33.16 | $47,710.33 | View Details |
| Sep 10, 2026 | Cohen Joshua B Director | Sale | 919 | $33.15 | $30,463.75 | View Details |
| Sep 10, 2026 | Cohen Joshua B Director | Sale | 29,545 | $32.16 | $950,040.16 | View Details |
| Jul 10, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 15,000 | $17.61 | $264,121.50 | View Details |
| Jul 9, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 15,000 | $18.32 | $274,746.00 | View Details |
27 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: